✦ LIBER ✦

A controlled trial of daily and intermittent rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis: Results up to 30 months

✍ Scribed by Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council; Reseach Council

Book ID: 113208248
Publisher: Elsevier Science
Year: 1975
Tongue: English
Weight: 965 KB
Volume: 56
Category: Article
ISSN: 0041-3879
DOI: 10.1016/0041-3879(75)90050-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A comparative study of daily followed by

A comparative study of daily followed by twice- or once-weekly regimens of ethambutol and rifampicin in the retreatment of patients with pulmonary tuberculosis: Second report

📂 Article 📅 1976 🏛 Elsevier Science 🌐 English ⚖ 730 KB

Controlled trial of 6-month and 8-month

Controlled trial of 6-month and 8-month regimens in the treatment of pulmonary tuberculosis: The results up to 24 months

✍ Hong Kong Chest Service/British Medical Research Council 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 876 KB

Clinical trial of six-month and four-mon

Clinical trial of six-month and four-month regimens of chemotherapy in the treatment of pulmonary tuberculosis: The results up to 30 months

✍ Tuberculosis Service/British Medical Research Council Singapore 📂 Article 📅 1981 🏛 Elsevier Science 🌐 English ⚖ 728 KB

Controlled trial of 4 three-times-weekly

Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis second report: the results up to 24 months

📂 Article 📅 1982 🏛 Elsevier Science 🌐 English ⚖ 447 KB

Rapid and sustained improvement in bone

Rapid and sustained improvement in bone and cartilage turnover markers with the anti–interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone

✍ Patrick Garnero; Elizabeth Thompson; Thasia Woodworth; Josef S. Smolen 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 3 views

## Abstract ## Objective To investigate the effects of tocilizumab (TCZ) added to a stable dosage of methotrexate (MTX) on biochemical markers of bone and cartilage metabolism in patients in the multicenter double‐blind, placebo‐controlled OPTION (Tocilizumab Pivotal Trial in Methotrexate Inadequa